Clare
Clare Berty, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20140089060 | DEMONSTRATING ORGANIZATIONAL TRANSPARENCY - A method of demonstrating organizational transparency is described. The method includes: defining a plurality of different groups of readers to whom organizations may elect to make a report available, wherein each group of readers has an associated transparency value; receiving a report which has an associated group of readers; calculating a transparency level of an organization by determining the transparency value of the associated group of readers to whom the report has been made available; and publishing the calculated transparency level of the organization. | 03-27-2014 |
Clare Christy, Sandwich GB
| Patent application number | Description | Published |
|---|---|---|
| 20100158933 | IGE CH3 PEPTIDE VACCINE - The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine. | 06-24-2010 |
| 20120294848 | IGE CH3 Peptide Vaccine - The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine. | 11-22-2012 |
| 20140017239 | IGE CH3 Peptide Vaccine - The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine. | 01-16-2014 |
Clare Corado, Indianapolis, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20140237697 | BELT DEVICE FOR SECURING THE EXTERNAL PORTION OF A CATHETER - The present novel technology relates to a medical device and/or medical garment that may be fittingly engaged to a patient or user by a generally elastic belt portion. When the medical garment is worn, it may be used to secure and support Central Venous Catheter lines or Intravenous lines. The lines are threaded through at least one enclosing flap located on the exterior surface of the generally elastic belt portion and secured within at least one compartment defined by the respective flap. Once the lines are secured in the respective compartment, the lines are relieved of tension, and more specifically the lines are relieved of tension at the site where the lines attach to the body. | 08-28-2014 |
Clare Golfier, La Neuveville CH
| Patent application number | Description | Published |
|---|---|---|
| 20100230290 | MOULD FOR GALVANOPLASTY AND METHOD OF FABRICATING THE SAME - The invention relates to a method ( | 09-16-2010 |
| 20100236934 | MOULD FOR GALVANOPLASTY AND METHOD OF FABRICATING THE SAME - The invention relates to a method ( | 09-23-2010 |
| 20130213800 | MOULD FOR GALVANOPLASTY AND METHOD OF FABRICATING THE SAME - The invention concerns the field of micromechanical parts, in particular, for timepiece movements. The invention relates to a method of fabricating a mould that includes the following steps: (a) providing a substrate that has a top layer and a bottom layer made of electrically conductive, micromachinable material, and secured to each other by an electrically insulating, intermediate layer; (b) etching at least one pattern in the top layer as far as the intermediate layer to form at least one cavity in the mould; (c) coating the top part of the substrate with an electrically insulating coating; and (d) directionally etching the coating and the intermediate layer to limit the presence thereof exclusively at each vertical wall formed in the top layer. | 08-22-2013 |
Clare Green, York GB
| Patent application number | Description | Published |
|---|---|---|
| 20150335917 | WOUND TREATMENT APPARATUS AND METHOD - An apparatus for cleansing wounds in which irrigant fluid from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are moved by a device (which may be a single pump or two pumps) for moving fluid through a flow path which passes through the dressing and a means for providing simultaneous aspiration and irrigation of the wound. The apparatus also comprises means to apply high frequency vibrational energy, e.g. ultrasound, to the wound bed. The former removes materials deleterious to wound healing, while distributing materials that are beneficial in promoting wound healing over the wound bed. The latter promotes healing. The dressing and a method of treatment using the apparatus. | 11-26-2015 |
Clare Heaysman, Farnham Surrey GB
| Patent application number | Description | Published |
|---|---|---|
| 20140030350 | Drug Delivery Systems - The present invention relates to microparticles comprising a gel body, wherein the gel body comprises a synthetic polymer and a drug, wherein the microparticles have an average diameter in the range 40 to 1500 μm, wherein the polymer is cross-linked by groups comprising disulfide linkages and is in the form of a hydrogel. | 01-30-2014 |
Clare Hoskins, St Albans GB
| Patent application number | Description | Published |
|---|---|---|
| 20120238487 | POLYMER COMPOSITION USEFUL AS A PHARMACEUTICAL CARRIER - A polymer having a structure according to the following formula (I): wherein: A represents a hydrophilic group; B represents a hydrophobic aromatic group such as 5-dimethylamino-1-naphthalenesulfonyl (Dansyl), 9-fluorenylmethoxy carbonyl (Fmoc) and naphthalene (Naphth); D and E independently represent amine groups; F represents an amine group, the amine group being substituted with a B group and an A group, or the amine group being a quaternary ammonium moiety; wherein W, X, Y and Z each independently have values greater than or equal to (1), especially in the range of (1) to (10). | 09-20-2012 |
Clare Hunckler, Mocksville, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110017413 | SHADE AND SHADING SYSTEM - A shading system for a window comprising a panel having a shape and size that covers at least a portion of the window when the panel is placed over the window. The shading system may include a first plurality of magnets in the panel and a second plurality of magnets for securement to the inside surface of the window. The first and second plurality of magnets removably securing the panel over the window of the vehicle. | 01-27-2011 |
Clare Johnson, Mannheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20080263462 | ENTERPRISE USER INTERFACE CUSTOMIZATION - In one embodiment, a method is illustrated as rendering an application User Interface (UI) to be modified to reflect a use case, and initiating a guided procedure relating to the use of an elected privilege to modify the application UI. Further, in one embodiment, a method is illustrated as including displaying a configuration rule, the configuration rule used to govern a UI configuration, detecting a selection of the configuration rule as an elected privilege relating to modifying a UI element and a layout element, and storing the elected privilege. In some cases, the UI is a Customer Relationship Management (CRM) UI. | 10-23-2008 |
Clare Jones, Amersham GB
| Patent application number | Description | Published |
|---|---|---|
| 20110027178 | IMAGING THE CENTRAL NERVOUS SYSTEM - The present invention provides novel compounds which may be used as in vivo imaging agents. The compounds of the invention are useful in a method to image the expression of P2X | 02-03-2011 |
| 20130230460 | USE OF CYANINE DYES FOR THE DETECTION OF TAU FOR DIAGNOSIS OF EARLY-STAGE TAUOPATHIES - Radiolabeled compounds useful as diagnostic imaging agents of Tau pathology in Alzheimer's disease are described. Compositions and methods of making such compounds are also described. | 09-05-2013 |
| 20130236395 | HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY - Heterocyclic compounds of formula (I) useful as imaging probes of Tau pathology in Alzheimer's disease are described. Compositions and methods of making such compounds are also described. | 09-12-2013 |
Clare Jones, Buckinghamshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080221804 | System of Processing Patient Medical Data - A system is described for assisting in the interpretation of medical images by making available information derived from other tests such as in vitro testing. In a preferred embodiment, an in vitro diagnostic testing device is integrated with a scanner such as a Positron Emission Tomography (PET) device so that both types of data can be simultaneously acquired and presented to the diagnosing physician. | 09-11-2008 |
Clare Jones, Liverpool GB
| Patent application number | Description | Published |
|---|---|---|
| 20130164201 | COMPOSITION BASED ON CERIUM, ZIRCONIUM AND TUNGSTEN, PREPARATION PROCESS AND USE IN CATALYSIS - A composition based on cerium, zirconium and tungsten is described. The composition has a content expressed as an oxide, of which cerium is from 5% to 30% of the composition, tungsten is from 2% to 17% of the composition, and the remainder of the composition is zirconium. After aging at 750° C. under an air atmosphere including 10% water, it has a two-phase crystallographic structure having a tetragonal zirconia phase and a monoclinic zirconia phase, with no presence of a crystalline phase including tungsten. The composition can be used as a catalyst, especially in an SCR process. | 06-27-2013 |
| 20130195743 | METHOD FOR TREATING A GAS CONTAINING NITROGEN OXIDES (NOX), IN WHICH A COMPOSITION COMPRISING CERIUM OXIDE AND NIOBIUM OXIDE IS USED AS A CATALYST - A method is described for treating a gas including nitrogen oxides (NO | 08-01-2013 |
Clare Jones, Crosby GB
| Patent application number | Description | Published |
|---|---|---|
| 20140044629 | METHOD FOR TREATING A GAS CONTAINING NITROGEN OXIDES (NOx) USING A COMPOSITION COMPRISING ZIRCONIUM, CERIUM AND NIOBIUM AS A CATALYST - The invention relates to a method for treating a gas containing nitrogen oxides (NOx), in which an NOx-reduction reaction is carried out using a nitrogen-containing reducing agent, which invention is characterized in that the catalyst used for the reduction reaction is a catalytic system containing a composition comprising zirconium, niobium in the following percentages by weight, expressed in terms of the weight of oxide: 10-50% of cerium, 5-20% of niobium and the remainder consisting of zirconium. | 02-13-2014 |
Clare Kasemest, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140215398 | INTERFACE SCANNING FOR DISABLED USERS - Systems and processes for scanning a user interface are disclosed. One process can include scanning multiple elements within a user interface by highlighting the elements. The process can further include receiving a selection while one of the elements is highlighted and performing an action on the element that was highlighted when the selection was received. The action can include scanning the contents of the selected element or performing an action associated with the selected element. The process can be used to navigate an array of application icons, a menu of options, a standard desktop or laptop operating system interface, or the like. The process can also be used to perform gestures on a touch-sensitive device or mouse and track pad gestures (e.g., flick, tap, or freehand gestures). | 07-31-2014 |
Clare Monteschio, Sebastopol, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140027594 | Sport Board Display Device - A device for displaying a sport board, such as a skateboard, on a flat surface, such as a wall or an angled ceiling, wherein the board may be displayed at any angle to maximize the artistic impact of the design. The display device includes a mounting plate, a spacer to accommodate the curvature of the sport board, and a board mounting bracket designed to accept bolts that are screwed into the opposite ends of the existing holes on a sport board deck. | 01-30-2014 |
Clare Notley, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20160030439 | METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES - The present invention provides a method for inducing CD8 | 02-04-2016 |
Clare Peters-Libeu, Sebastopol, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100099609 | eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE - This invention provides methods of reducing levels of amyloid beta (Aβ) protein and/or netrin-1 in a mammal. In certain embodiments the methods involve administering to the mammal a fragment of an amyloid precursor protein, or a mutant amyloid precursor protein, in an amount sufficient to decrease circulating levels of free Aβ protein in said mammal, wherein said fragment is a fragment of the extracellular domain of APP or a mutant thereof that binds amyloid beta protein and/or netrin-1. | 04-22-2010 |
| 20130017251 | Antibody Specific for Apolipoprotein and Methods of Use Thereof - The present disclosure provides synthetic antibodies specific for an epitope present on an apolipoprotein E polypeptide. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided. | 01-17-2013 |
| 20150017148 | NETRIN LOOP PEPTIDE MIMETICS AND USES THEREOF - In certain embodiments compositions are provided that comprise a pentapeptide comprising the formula: C | 01-15-2015 |
Clare Selden, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110125286 | MULTI-FUNCTIONAL CHAMBER FOR HOUSING A BIOLOGICAL COMPONENT - The present invention relates to the field of extracorporeal liver perfusion and, more particularly, to the design of a chamber in which a biological component can be housed to form e.g. a bio-artificial liver (BAL). It also relates to a bio-artificial liver per se, it's components and methodological steps associated with its development and use. The chamber ( | 05-26-2011 |
| 20110313540 | IN OR RELATING TO GROWING CELLS - The present invention relates to a method of growing a plurality of cells ( | 12-22-2011 |